Jordan Park

Jordan Park

Healthcare & Biotech Analyst

Healthcare and biotech analyst focused on pharma pipelines, medtech adoption curves, and reimbursement dynamics. Former clinical research coordinator and later equity research analyst. Writes thesis-driven pieces that connect clinical catalysts, competitive landscapes, and valuation scenarios.

Articles 769

Jan 24, 2026 Trade Ideas

Kiniksa: Arcalyst Fuels the Business, KPL-387 Could Turbocharge the Re-rating

Long idea: buy the revenue-backed biotech with a clinical-stage accelerator—entry 40-44, stop 34, target 58/75

Kiniksa is trading like a growth biotech but with a commercial engine. Arcalyst (rilonacept) is delivering sequential revenue and profitability; cash ...

Trade Idea Long
Jan 23, 2026 Finance

SanDisk Shares Retrace After Historic Surge Amid AI Memory Demand

Investor Profit-Taking and Valuation Concerns Temper SanDisk’s Continued Gains In A Robust AI-Driven Memory Market

SanDisk Corporation has witnessed an extraordinary stock price increase exceeding 1,200% within the past year, predominantly fueled by soaring demand ...

Unseen Errors in Your Social Security Earnings Record Could Slash Retirement Benefits
Jan 23, 2026 Business News

Unseen Errors in Your Social Security Earnings Record Could Slash Retirement Benefits

Understanding and Correcting Mistakes That May Reduce Your Lifetime Social Security Income

Maximizing Social Security benefits involves careful planning and vigilance, particularly in ensuring your earnings record is accurate. Mistakes in th...

Jan 23, 2026 Finance

Fintech Firms Diverge in Prediction Market Strategies Amid Regulatory Challenges

Robinhood Embraces Sports Betting While Interactive Brokers Targets Utility-Based Contracts

The fintech landscape for prediction markets, currently valued at $63.5 billion, is witnessing contrasting strategic approaches by major players. Inte...

Jan 23, 2026 Finance

Life360 Raises Fiscal 2025 Revenue Targets Amid Strong User Growth

Enhanced Sales Outlook Drives Shares Higher Despite Mixed Technical Signals

Life360 Inc has elevated its fiscal year 2025 revenue projections following robust fourth-quarter user engagement, leading to significant gains in its...

Jan 23, 2026 Finance

Broadcom's Market Trajectory: AI Demand Inspires Analyst Confidence Amid Volatility

Analysts highlight AI-driven growth prospects in chip and software business despite short-term stock pressures

Broadcom Inc (NASDAQ:AVGO) is currently navigating a complex market environment with its shares experiencing a decline amid rising investor enthusiasm...

Jan 23, 2026 Finance

FDA Flags Potential Sterility Concerns in Integra LifeSciences Wound Care Products

Packaging and production issues prompt product recalls amid infection risk warnings

The FDA's Center for Devices and Radiological Health has alerted the public to potential infection risks associated with certain Integra LifeSciences ...

Jan 23, 2026 Finance

Capital One Faces Market Pressure Following Earnings Shortfall and Brex Acquisition Announcement

Shares slide amid lower-than-expected Q4 earnings per share and $5.15 billion deal to acquire fintech Brex

Capital One Financial's shares declined significantly on the news of its fourth-quarter earnings per share falling short of analyst expectations and t...

Jan 23, 2026 Finance

USA Rare Earth Advances Texas Mining Project Amid Mixed Stock Signals

Engineering Partnerships and Drilling Plans Mark Progress While Stock Exhibits Volatile Momentum

USA Rare Earth Inc is progressing its Sierra Blanca, Texas, mining project through new engineering partnerships and preparatory activities. The compan...

Jan 23, 2026 Finance

CSX Faces Analyst Target Cuts Following Disappointing Fourth Quarter Earnings

Revenue and earnings miss expectations amid industrial demand concerns and cost restructuring efforts.

CSX Corporation released its fourth quarter financial results, revealing earnings per share and revenues below analyst expectations. The company cited...